Search Results - "Chamberlain, Bruce"

Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness by Thomas, Jay, Karver, Sloan, Cooney, Gail Austin, Chamberlain, Bruce H, Watt, Charles Kevin, Slatkin, Neal E, Stambler, Nancy, Kremer, Alton B, Israel, Robert J

“…This study investigated the safety and efficacy of subcutaneous methylnaltrexone, a μ-opioid–receptor antagonist, for treating opioid-induced constipation in…”
Get full text

Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose by Chamberlain, Bruce H, Rhiner, Michelle, Slatkin, Neal E, Stambler, Nancy, Israel, Robert J

“…Opioid-induced constipation (OIC) is a common side effect of opioid therapy. Methylnaltrexone (MNTX) is a selective, peripherally acting μ-opioid receptor…”
Get full text

Methylnaltrexone Treatment of Opioid-Induced Constipation in Patients with Advanced Illness by Chamberlain, Bruce H., MD, Cross, Karen, MD, Winston, Jaron L., MD, Thomas, Jay, MD, Wang, Wenjin, PhD, Su, Chinyu, MD, Israel, Robert J., MD

“…Abstract Methylnaltrexone, a peripherally acting mu-opioid receptor antagonist with restricted ability to cross the blood-brain barrier, reverses…”
Get full text

Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies by Chamberlain, Bruce H, Rhiner, Michelle, Slatkin, Neal E, Stambler, Nancy, Israel, Robert J

“…Methylnaltrexone inhibits opioid-induced constipation (OIC) by binding to peripheral µ-opioid receptors without impacting central opioid receptor mediated…”
Get full text

Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials by Shah, Eric D, Chamberlain, Bruce H, Rhiner, Michelle, Slatkin, Neil E, Stambler, Nancy, Israel, Robert J

“…To evaluate the efficacy and safety of subcutaneous (SC) methylnaltrexone for opioid-induced constipation (OIC) in patients with and without active cancer. We…”
Get full text

Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer by Chamberlain, Bruce H, Rhiner, Michelle, Slatkin, Neal E, Stambler, Nancy, Israel, Robert J

“…To evaluate methylnaltrexone for opioid-induced constipation in patients with and without cancer. This analysis comprises two Phase III, multicenter,…”
Get full text

Palliative Wound Care (P12) by Alvarez, Oscar, PhD CCT FAPWCA, Chamberlain, Bruce, MD FACP FAAHPM, Tippett, Aletha, MD HMDC

Get full text

Treatment with Methylnaltrexone in Patients with Opioid-Induced Constipation with or Without Active Cancer (S812) by Chamberlain, Bruce, Rhiner, Michelle, Slatkin, Neal, Stambler, Nancy, Israel, Robert

Get full text

Efficacy Variables in Cancer Versus Noncancer Patients Treated with Methylnaltrexone or Placebo: An Analysis of 2 Placebo-Controlled Studies (S811) by Chamberlain, Bruce, Rhiner, Michelle, Slatkin, Neal, Stambler, Nancy, Israel, Robert

Get full text

S0493 Subcutaneous Methylnaltrexone in Cancer and Non-Cancer Patients for Rapid Relief of Opioid-Induced Constipation by Shah, Eric D., Chamberlain, Bruce H., Rhiner, Michelle, Slatkin, Neal E., Stambler, Nancy, Israel, Robert J.

Get full text

Su1648 – Efficacy Variables in Cancer Versus Noncancer Patients Treated with Methylnaltrexone Or Placebo: An Analysis of Two Placebo-Controlled Studies by Chamberlain, Bruce H., Rhiner, Michelle I., Slatkin, Neal E., Stambler, Nancy, Israel, Robert J.

Get full text

Efficacy variables in patients with cancer versus patients without cancer treated with methylnaltrexone or placebo: An analysis of two placebo-controlled studies by Chamberlain, Bruce, Rhiner, Michelle, Slatkin, Neal E, Stambler, Nancy, Israel, Robert Joseph

“…Abstract only 1 Background: A post-hoc analysis of pooled data from two randomized, double-blind studies and their open-label extensions evaluated whether…”
Get full text

Subcutaneous Methylnaltrexone as Treatment for Opioid-lnduced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials by Shah, Eric D, Chamberlain, Bruce H, Rhiner, Michelle, Slatkin, Neil E, Stambler, Nancy, Israel, Robert J

“…Purpose: To evaluate the efficacy and safety of subcutaneous (SC) methylnaltrexone for opioid-induced constipation (OIC) in patients with and without active…”
Get full text

Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients by Becker, D M, Chamberlain, B, Swank, R, Hegewald, M G, Girardet, R, Baughman, K L, Kwiterovich, P O, Pearson, T A, Ettinger, W H, Renlund, D

“…Accelerated coronary atherosclerosis is a major cause of heart graft failure two years and more after heart transplantation, yet its etiology remains…”
Get more information

For Those Who Practice Pain Management in the Trenches by Chamberlain, Bruce

Get full text

Education and training by Chamberlain, Bruce, Portenoy, Russell K

Get more information

What’s in a name? by Chamberlain, Bruce H.

Get full text

What’s in a name? by Chamberlain, Bruce H.

Get full text

Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose by Chamberlain, Bruce H, Rhiner, Michelle, Slatkin, Neal E, Stambler, Nancy, Israel, Robert J

“…PurposeOpioid-induced constipation (OIC) is a common side effect of opioid therapy. Methylnaltrexone (MNTX) is a selective, peripherally acting μ-opioid…”
Get full text

Current status of diagnosis and management of strangulation obstruction of the small bowel by Shatila, A H, Chamberlain, B E, Webb, W R

Get more information